Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The global immune checkpoint inhibitors industry generated $34.9B in 2021, and is anticipated to generate $155.1B by 2031, witnessing a CAGR of 16.1% from 2022 to 2031, according to a report from Allied Market Research.
read more
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused, announced that it has partnered with Celltrion for the development of RT-111, an orally administered ustekinumab biosimilar.
read more
Vivera expanded ts license for TABMELT technology to Israel, the company announced. TABMELT provides sublingual drug delivery.
read more
Acorda Therapeutics announced that it has entered into a long-term global supply agreement with Catalent to manufacture INBRIJA (levodopa inhalation powder) in Boston through 2030.
read more
Growing demand for pharmaceutical products, along with the increasing penetration of retail sales of drugs or pharmaceuticals in developing regions, are estimated to enhance market growth, according to projections from Research & Markets.
read more
WuXi STA,a subsidiary of WuXi AppTec, announced that its first drug product continuous manufacturing (CM) line for oral solids is in operation at the drug product site located in Wuxi city, China.
read more
The global probiotic dietary supplement market size reached$6.4B in 2021 and is projected to . reach $10B by 2027, exhibiting a CAGR of 7.72% during 2021-2027, according to a report by Research & Markets.
read more
The global hormone replacement therapy market is expected to reach$ 25B by 2027, according to a report by Research & Markets.
read more
The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application for palovarotene, an investigational treatment for the reduction of new abnormal bone formation (heterotopic ossification) in people living with fibrodysplasia ossificans progressiva (FOP).
read more
Hetero, an Indian pharmaceutical company, announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir.
read more
The vitamin D market size is estimated to be valued at $1.3B in 2022 and is projected to reach $1.9B by 2027, recording a CAGR of 7.1% during the forecast period, according to a report by Research & Markets.
read more
Lupin Pharmaceuticals is voluntarily recalling four lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level.
read more
The complementary and alternative medicine (CAM) market was valued at $100.04B in 2021 and is expected to reach $477.29B by 2029, registering a CAGR of 21.57% during the forecast period of 2022 to 2029, according to a report by Data Bridge Market Research.
read more
In 2017, the herpes treatment market was valued at $3.7B, with North America holding the largest market share, valued at $1.7B. The herpes treatment market size is estimated to grow by $920.28M from 2023 to 2027, according to a report by Technavio.
read more
ANI Pharmaceuticals announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Levocarnitine Tablets USP, 330 mg.
read more